Supergen Inc Sample Contracts

SECTION 1
Registration Rights Agreement • January 7th, 2000 • Supergen Inc • Pharmaceutical preparations • Delaware
AutoNDA by SimpleDocs
BETWEEN
License Agreement • March 16th, 2000 • Supergen Inc • Pharmaceutical preparations • Nevada
RECITALS
Assignment and Assumption Agreement • May 15th, 1997 • Supergen Inc • Pharmaceutical preparations
WITNESSETH:
Purchase and Sale Agreement • October 15th, 1996 • Supergen Inc • Pharmaceutical preparations • Delaware
COMMON STOCK
Underwriting Agreement • March 16th, 2000 • Supergen Inc • Pharmaceutical preparations • New York
WITNESSETH:
Research Agreement • January 21st, 2000 • Supergen Inc • Pharmaceutical preparations • Nevada
RECITALS
Registration Rights Agreement • January 21st, 2000 • Supergen Inc • Pharmaceutical preparations • Delaware
W I T N E S S E T H:
Registration Rights Agreement • March 31st, 1999 • Supergen Inc • Pharmaceutical preparations • Delaware
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • March 10th, 2004 • Supergen Inc • Pharmaceutical preparations

This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 5, 2004, by and among SuperGen, Inc., a Delaware corporation (the “Company”), and the purchasers signatory hereto (each such purchaser, a “Purchaser” and collectively, the “Purchasers”).

BACKGROUND
Stock Purchase Agreement • March 31st, 1999 • Supergen Inc • Pharmaceutical preparations • California
AIR
Lease Agreement • November 5th, 1997 • Supergen Inc • Pharmaceutical preparations
BACKGROUND
Asset Purchase Agreement • March 23rd, 2001 • Supergen Inc • Pharmaceutical preparations • California
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • October 1st, 2002 • Supergen Inc • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of September 23, 2002, among SuperGen, Inc., a Delaware corporation (the “Company”), and the purchasers identified on the signature pages hereto (each a “Purchaser” and collectively the “Purchasers”).

W I T N E S S E T H:
Registration Rights Agreement • May 14th, 1999 • Supergen Inc • Pharmaceutical preparations • Delaware
FORM OF SUBSCRIPTION AGREEMENT
Subscription Agreement • February 20th, 2009 • Supergen Inc • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • June 25th, 2003 • Supergen Inc • Pharmaceutical preparations • New York

SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 24, 2003 by and among SuperGen, Inc., a Delaware corporation, with headquarters located at 4140 Dublin Boulevard, Suite 200, Dublin, California 94568 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).

AutoNDA by SimpleDocs
WARRANT AGREEMENT BETWEEN SUPERGEN, INC. AND
Warrant Agreement • July 2nd, 1999 • Supergen Inc • Pharmaceutical preparations • California
SUPPLY AGREEMENT between SUPERGEN, INC. and
Supply Agreement • October 31st, 1997 • Supergen Inc • Pharmaceutical preparations • Delaware
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • February 27th, 2003 • Supergen Inc • Pharmaceutical preparations • New York

SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 26, 2003 by and among SuperGen, Inc., a Delaware corporation, with headquarters located at 4140 Dublin Boulevard, Suite 200, Dublin, California 94568 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).

EXHIBIT 10.25 [*] REDACTED CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENT
License Agreement • May 15th, 1997 • Supergen Inc • Pharmaceutical preparations • California
SUPERGEN, INC.
Common Stock and Option Purchase Agreement • January 7th, 2000 • Supergen Inc • Pharmaceutical preparations • Delaware
RECITALS
License Agreement • October 6th, 1997 • Supergen Inc • Pharmaceutical preparations • New York
FORM OF SUBSCRIPTION AGREEMENT
Subscription Agreement • March 26th, 2012 • Astex Pharmaceuticals, Inc • Pharmaceutical preparations • New York

o A. Delivery by crediting the account of the Investor’s prime broker (as specified by such Investor on Exhibit A annexed hereto) through the Depository Trust Company’s (“DTC”) Deposit/Withdrawal At Custodian (“DWAC”) system, whereby Investor’s prime broker shall initiate a DWAC transaction on the Closing Date using its DTC participant identification number, and the Shares are released by [insert name of transfer agent], the Company’s transfer agent (the “Transfer Agent”), at the Company’s direction. NO LATER THAN ONE (1) BUSINESS DAY AFTER THE EXECUTION OF THIS AGREEMENT BY THE INVESTOR AND THE COMPANY, THE INVESTOR SHALL:

AGREEMENT AND PLAN OF MERGER by and among OTSUKA PHARMACEUTICAL CO., LTD., AUTUMN ACQUISITION CORPORATION and ASTEX PHARMACEUTICALS, INC. Dated as of September 5, 2013
Merger Agreement • September 5th, 2013 • Astex Pharmaceuticals, Inc • Pharmaceutical preparations • Delaware

THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of September 5, 2013 by and among OTSUKA PHARMACEUTICAL CO., LTD., a Japanese joint stock company (“Parent”), AUTUMN ACQUISITION CORPORATION, a Delaware corporation and a direct or indirect, wholly-owned subsidiary of Parent (“Acquisition Sub”), and ASTEX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”).

SUPERGEN, INC. AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AND CONFIDENTIAL INFORMATION AND INVENTION ASSIGNMENT AGREEMENT
Executive Employment and Confidential Information and Invention Assignment Agreement • October 31st, 2008 • Supergen Inc • Pharmaceutical preparations • California

This Amended and Restated Executive Employment and Confidential Information and Invention Assignment Agreement (the “Agreement”) is made and entered into as of October 28, 2008 (the “Effective Date”) by and between SuperGen, Inc., a Delaware corporation (the “Company”), and James S. Manuso (“Executive”).

REPLACEMENT OPTION AGREEMENT relating to the Astex Technology Limited Enterprise Management Incentive Share Scheme 2002
Replacement Option Agreement • July 25th, 2011 • Supergen Inc • Pharmaceutical preparations
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!